Search research articles
Contact Us
Filters
Showing results (131-140 of 192) with videos related to
Page
of 20
Sort By:
JHEP Reports : Innovation in Hepatology
|
December 24, 2024
Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong Kong
Zeyuan Yang, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
June 24, 2026
Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management
Dhweeja Dasarathy, Jeremy W Luk, Amy M Shui, et al.
Journal of Hepatology
|
April 11, 2023
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
Michael H Le, David M Le, Thomas C Baez, et al.
Digestive Diseases and Sciences
|
March 31, 2015
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir
Kevin P Vo, Philip Vutien, Matthew J Akiyama, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
Clinical and Molecular Hepatology
|
January 28, 2024
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H Le, David M Le, Thomas C Baez, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2023
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration
Bryan D Badal, Scott Silvey, Lyuba Dragilev, et al.
Digestive Diseases and Sciences
|
April 10, 2016
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
Myrna L Cozen, James C Ryan, Hui Shen, et al.
The Journal of Infectious Diseases
|
June 12, 2020
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
An K Le, Hwai-I Yang, Ming-Lun Yeh, et al.
Hepatology Communications
|
February 5, 2024
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis
Jeremy W Luk, Derek D Satre, Ramsey Cheung, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 192) with videos related to
Sort By:
Page
of 20
JHEP Reports : Innovation in Hepatology
|
December 24, 2024
Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong Kong
Zeyuan Yang, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
June 24, 2026
Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management
Dhweeja Dasarathy, Jeremy W Luk, Amy M Shui, et al.
Journal of Hepatology
|
April 11, 2023
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
Michael H Le, David M Le, Thomas C Baez, et al.
Digestive Diseases and Sciences
|
March 31, 2015
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir
Kevin P Vo, Philip Vutien, Matthew J Akiyama, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
Clinical and Molecular Hepatology
|
January 28, 2024
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H Le, David M Le, Thomas C Baez, et al.
Hepatology (Baltimore, Md.)
|
January 16, 2023
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration
Bryan D Badal, Scott Silvey, Lyuba Dragilev, et al.
Digestive Diseases and Sciences
|
April 10, 2016
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
Myrna L Cozen, James C Ryan, Hui Shen, et al.
The Journal of Infectious Diseases
|
June 12, 2020
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
An K Le, Hwai-I Yang, Ming-Lun Yeh, et al.
Hepatology Communications
|
February 5, 2024
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis
Jeremy W Luk, Derek D Satre, Ramsey Cheung, et al.
Page
of 20